Truist Financial Forecasts Strong Price Appreciation for Sabra Healthcare REIT (NASDAQ:SBRA) Stock

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective raised by stock analysts at Truist Financial from $20.00 to $21.00 in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective indicates a potential upside of 8.75% from the stock’s current price.

A number of other analysts have also weighed in on SBRA. Jefferies Financial Group reaffirmed a “buy” rating and set a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Cantor Fitzgerald assumed coverage on Sabra Healthcare REIT in a report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price target on the stock. Wells Fargo & Company increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Finally, UBS Group started coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, November 18th. They set a “neutral” rating and a $20.00 target price on the stock. Four investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $21.11.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $19.31 on Tuesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19. The company has a market cap of $4.81 billion, a P/E ratio of 26.82, a P/E/G ratio of 1.17 and a beta of 0.67. The stock has a 50-day moving average of $19.04 and a two-hundred day moving average of $18.69. Sabra Healthcare REIT has a 1-year low of $15.60 and a 1-year high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The business had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. During the same quarter last year, the firm posted $0.37 earnings per share. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, analysts anticipate that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors have recently modified their holdings of the company. Focus Partners Wealth boosted its position in shares of Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after buying an additional 2,375 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Sabra Healthcare REIT by 23.6% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 12,748 shares of the real estate investment trust’s stock valued at $237,000 after purchasing an additional 2,433 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of Sabra Healthcare REIT by 2.0% in the second quarter. Exchange Traded Concepts LLC now owns 48,718 shares of the real estate investment trust’s stock valued at $898,000 after purchasing an additional 936 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Sabra Healthcare REIT by 28.5% in the second quarter. GAMMA Investing LLC now owns 6,874 shares of the real estate investment trust’s stock valued at $127,000 after purchasing an additional 1,525 shares during the last quarter. Finally, Ballentine Partners LLC increased its stake in shares of Sabra Healthcare REIT by 8.7% during the 2nd quarter. Ballentine Partners LLC now owns 13,568 shares of the real estate investment trust’s stock worth $250,000 after purchasing an additional 1,090 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.